Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Ozempic and other GLP-1 drugs like it have become so pervasive in the zeitgeist that it’s likely even your most social ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...